ArticleAnnals of hematology2019

Single-agent ibrutinib in RESONATE-2™ and RESONATE™ versus treatments in the real-world PHEDRA databases for patients with chronic lymphocytic leukemia.

Gilles Salles et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.